PMID- 11104691 OWN - NLM STAT- MEDLINE DCOM- 20010201 LR - 20181113 IS - 0264-6021 (Print) IS - 1470-8728 (Electronic) IS - 0264-6021 (Linking) VI - 352 Pt 3 IP - Pt 3 DP - 2000 Dec 15 TI - Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C. PG - 817-26 AB - Monocyte chemoattractant protein-1 (MCP-1) is a potent chemokine that stimulates the migration of monocytes into the intima of arterial walls. Although many factors that induce MCP-1 expression have been identified, the effect of homocysteine on the expression of MCP-1 in atherogenesis and the underlying mechanisms are not entirely clear. The objective of the present study was to investigate the role of homocysteine in MCP-1 expression in human aorta vascular smooth-muscle cells (VSMCs). After VSMCs were incubated with homocysteine for various time periods, a nuclease protection assay and ELISA were performed. Homocysteine (0.05-0.2 mM) significantly increased the expression of MCP-1 mRNA (up to 2. 7-fold) and protein (up to 3.3-fold) in these cells. The increase in MCP-1 expression was associated with the activation of protein kinase C (PKC) as well as nuclear factor kappaB (NF-kappaB). Further investigation demonstrated that the activation of NF-kappaB was the result of a PKC-mediated reduction in the expression of inhibitory protein (IkappaBalpha) mRNA and protein in homocysteine-treated cells. Oxidative stress might also be involved in the activation of NF-kappaB by homocysteine in VSMCs. In conclusion, the present study has clearly demonstrated that the activation of PKC as well as superoxide production followed by activation of NF-kappaB is responsible for homocysteine-induced MCP-1 expression in VSMCs. These results suggest that homocysteine-stimulated MCP-1 expression via NF-kappaB activation may play an important role in atherogenesis. FAU - Wang, G AU - Wang G AD - Department of Pharmacology, Institute of Cardiovascular Science and Medicine, Faculty of Medicine, University of Hong Kong, 1/F, Li Shu Fan Building, 5 Sassoon Road, Pokfulam, Hong Kong, People's Republic of China. FAU - Siow, Y L AU - Siow YL FAU - O, K AU - O K LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Biochem J JT - The Biochemical journal JID - 2984726R RN - 0 (Chemokine CCL2) RN - 0 (DNA-Binding Proteins) RN - 0 (I-kappa B Proteins) RN - 0 (NF-kappa B) RN - 0 (NFKBIA protein, human) RN - 0 (Phosphoproteins) RN - 0 (RNA, Messenger) RN - 0LVT1QZ0BA (Homocysteine) RN - 139874-52-5 (NF-KappaB Inhibitor alpha) RN - 9007-49-2 (DNA) RN - EC 1.15.1.1 (Superoxide Dismutase) RN - EC 2.7.11.13 (Protein Kinase C) RN - SY7Q814VUP (Calcium) SB - IM MH - Blotting, Western MH - Calcium/metabolism MH - Cell Line MH - Chemokine CCL2/*biosynthesis/genetics/metabolism MH - DNA/genetics/metabolism MH - DNA-Binding Proteins/biosynthesis/genetics/metabolism MH - Enzyme Activation/drug effects MH - Enzyme-Linked Immunosorbent Assay MH - Homocysteine/*pharmacology MH - Humans MH - *I-kappa B Proteins MH - Models, Biological MH - Muscle, Smooth, Vascular/cytology/*drug effects/enzymology/metabolism MH - NF-KappaB Inhibitor alpha MH - NF-kappa B/antagonists & inhibitors/*metabolism MH - Nuclease Protection Assays MH - Oxidative Stress/drug effects MH - Phosphoproteins/biosynthesis/genetics/metabolism MH - Protein Binding/drug effects MH - Protein Kinase C/antagonists & inhibitors/*metabolism MH - RNA, Messenger/analysis/genetics MH - Superoxide Dismutase/antagonists & inhibitors/metabolism MH - Up-Regulation/drug effects PMC - PMC1221522 EDAT- 2000/12/06 11:00 MHDA- 2001/02/28 10:01 PMCR- 2001/06/15 CRDT- 2000/12/06 11:00 PHST- 2000/12/06 11:00 [pubmed] PHST- 2001/02/28 10:01 [medline] PHST- 2000/12/06 11:00 [entrez] PHST- 2001/06/15 00:00 [pmc-release] PST - ppublish SO - Biochem J. 2000 Dec 15;352 Pt 3(Pt 3):817-26.